Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rang în acțiuni #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Preț acțiune
$2.03
Capitalizare de piață
$121.44M
Schimbare (1 zi)
-0.93%
Schimbare (1 an)
-1.97%
Țară
FR
Tranzacționează Crossject Société Anonyme (ALCJ)

Categorie

Raport P/S pentru Crossject Société Anonyme (ALCJ)
Raport P/S la data de July 2026 TTM: 71.80
Conform celor mai recente rapoarte financiare și prețului acțiunilor Crossject Société Anonyme, raportul P/S actual (TTM) este 71.80. La sfârșitul anului 2023, compania avea un P/S de 1.26K.
Istoricul raportului P/S pentru Crossject Société Anonyme din 2010 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 71.80 194.15%
2024 24.41 -98.06%
2023 1.26K 911.76%
2022 124.63 55.54%
2021 80.13 434.26%
2020 15.00 -83.59%
2019 91.39 1,279.32%
2018 6.63 -47.30%
2017 12.57 -44.75%
2016 22.76 -47.42%
2015 43.28 8.99%
2014 39.71 -21.42%
2013 50.54 -54.97%
2012 112.23 83.88%
2011 61.03 -69.23%
2010 198.36 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
13.31 -81.46%
US
2.65 -96.31%
FR
4.46 -93.79%
DE
9.16 -87.24%
JP
2.57 -96.43%
US